New York City, NY -- (SBWIRE) -- 03/14/2017 -- Immunochemistry is a branch of science that deals with the study of the immune system. Immunochemical methods do not require extensive and destructive sample preparation and expensive instrumentation. Most immunochemical methods are based on simple photo, fluoro or luminometric detection. These methods have rapidly replaced chromatographic techniques in clinical diagnostics and offer fast detection of antibodies associated with specific diseases, hormones, disease biomarkers, and pharmaceuticals. Most commonly used assays in clinical immunochemistry involve either quantitative or qualitative formats using enzyme-linked immunosorbent assays (ELISAs), immunochromatography in the form of lateral-flow devices like dip-sticks and test strips, and Western Blot assays used to interpret data from protein analysis with gel electrophoresis. Moreover, it is also used in food safety assessment, environmental analysis, and the target chemical structures cover the widest range of molecular weight approximately hundreds of kilo Dalton (kD). Immunochemicals also develop antibody assays for cholera, anthrax, and diphtheria toxins.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/4127

The global immunochemicals market is categorized based on various types of antibodies. The report covers custom antibodies and catalog antibodies. Custom antibodies represent the fastest growing segment of the market. This is due to increasing demand for custom antibodies in genomic and proteomic research.

In terms of geography, North America dominates the global immunochemicals market. This is due to increased awareness about therapeutic applications of immunochemicals in disease management in the region. Moreover, improved life science studies and healthcare infrastructures are also supporting the growth of the immunochemicals market in North America. The U.S. represents the largest market for immunochemicals in North America, followed by Canada. In Europe, Germany, France, and the U.K. hold major shares in the immunochemicals market. The immunochemicals market in Asia too, is expected to show high growth rates in the next five years. This is due to advancements in the biotechnology sector which increased the demand of antibodies in research activities. Furthermore, improved government support for biotechnology research and emergence of India and China as major centers for clinical research are also favoring the growth of this market in the region. Availability of infrastructure facilities and low-cost workforce are fuelling the growth of clinical research organization (CRO) market. This, in turn. is increasing the demand for immunochemicals assays in the region.

Advancements in antibody technology and increasing prevalence of cancer are key drivers for the global immunochemicals market. Antibodies are used as tools in various applications, including expression levels of cancer-related proteins, signaling pathways, identification of candidate biomarkers, and analysis of enzyme activities.

Increasing investment in life science research activities and CRO market has also fueled the growth of the global immunochemicals market. Moreover, increase in research efforts for improving food production, enhancing food nutrition and quality, as well as production of pharmaceutical products through genetically engineered plants is also propelling the demand for immunochemicals.

However, stringent regulations set by various governments hamper the growth of the immunochemicals market. Increasing number of mergers and acquisitions of drug manufacturing companies and biotechnology research organizations is a key trend in the global immunochemicals market.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/4127

The major companies operating in this market are Advanced ImmunoChemical, Inc., BIOTREND Chemikalien GmbH, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Meridian Life Science, Inc., Maine Biotechnology Services, EMD Millipore, Randox Laboratories Ltd., MitoSciences Inc., F. Hoffmann-La Roche AG, Sigma-Aldrich Corporation, Rockland Immunochemicals, and Trinity Biotech plc.